NVAX NOVAVAX INC: institutional ownership and insider trading

283 funds reported holding $1.32B of NOVAVAX INC in their latest 13F filings; in Q2 2026 funds net bought $22.4M, with 39 new positions and 30 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $414M and net income of −$248M.

NVAX revenue and earnings

Famous investors holding NVAX

Largest institutional holders of NVAX

  1. SHAH CAPITAL MANAGEMENT — $132M
  2. BlackRock, Inc. (BLK) — $131M
  3. STATE STREET CORP (STT, STT-PG) — $111M
  4. VANGUARD GROUP INC — $104M
  5. VANGUARD PORTFOLIO MANAGEMENT LLC — $71.7M
  6. VANGUARD CAPITAL MANAGEMENT LLC — $68.4M
  7. Sanofi (SNY, SNYNF) — $64.8M
  8. D. E. Shaw & Co., Inc. — $56.8M
  9. GEODE CAPITAL MANAGEMENT, LLC — $39.6M
  10. TWO SIGMA INVESTMENTS, LP — $38.5M

Recent NVAX insider trades

5%+ owners

Who owns the most NVAX stock?

The largest institutional holders of NOVAVAX INC in the latest 13F filings are SHAH CAPITAL MANAGEMENT ($132M), BlackRock, Inc. (BLK) ($131M), STATE STREET CORP (STT, STT-PG) ($111M).

Are insiders buying or selling NVAX?

No open-market insider buys or sells of NOVAVAX INC were reported in the last 12 months.

Which famous investors own NVAX?

Philippe Laffont, D. E. Shaw, Two Sigma, Izzy Englander, Renaissance Technologies.

What was NVAX's revenue last quarter?

NOVAVAX INC reported revenue of $56.7M for the quarter ended June 30, 2026, with net income of −$53.4M.

Which ETFs hold NVAX?

8 ETFs and mutual funds hold it among their top 100 positions, including XBI, IDNA, EES, LABU.

All NVAX 13F holders · All NVAX insider trades